MEDACTA-INTERNATIONAL

Medacta International, a privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products, today announced the opening of its 7^th Medacta Orthopedic Research and Education (M.O.R.E.) International Symposium, which takes place this weekend near the company’s worldwide headquarters in Lugano, Switzerland. During the two-day event, more than 700 surgeon attendees will hear from a faculty of internationally recognized experts on topics including surgical best practices, emerging clinical data, and planned enhancements for Medacta knee, hip, and spine surgery products. The Symposium also coincides with a special milestone as Medacta celebrates its fifteenth anniversary and legacy as a patient-founded, patient-focused organization.

The M.O.R.E. International Symposium underscores Medacta’s commitment to furthering the surgical education and training that has been shown to improve patient safety and reduce the cost of orthopedic care and recovery. This year’s event features separate days dedicated to knee and hip replacement technologies and procedures, including reviews of the current treatment landscapes, clinical research, case studies and previews of forthcoming product innovations. More than 40 orthopedic surgery experts from around the world will present, with Frédéric Laude, MD (Clinique Paris V, Paris, FR) and Joel Matta, MD (Hip and Pelvis Institute, Santa Monica, CA) serving as chairmen of the Hip Program. Craig Loucks, MD and Robert Greenhow, MD (Peak Orthopedics, Denver, CO) will chair the Knee Program. Professor Michael Freeman, MD (Royal University Hospital/University College London, UK) will participate as honorary chairman, with the keynote address delivered by Daniel Berry, MD (Mayo Clinic, Rochester, MN).

“Medacta is unique in its focus on surgeon education and training, and its approach to collaborating with the surgical community to improve the art, science, and outcomes of orthopedic procedures,” said Dr. Frédéric Laude, a pioneer in the anterior approach to hip replacement and a co-chair of the Symposium’s Hip Program. “Having taught many anterior hip replacement courses myself, I’ve seen firsthand the impact that education, mentorship, and a robust training curriculum can have on surgical efficiency and the patient experience.”

Medacta will also recognize its fifteenth anniversary at the M.O.R.E. International Symposium this weekend. Medical technology veteran and entrepreneur Dr. Alberto Siccardi founded the company in 1999 after a personal experience with joint replacement compelled him to seek out opportunities to improve the experience for fellow patients. Since its founding, Medacta has grown significantly: it now employs more than 450 personnel in 26 countries worldwide, and develops and markets a suite of more than 50 hip, knee, and spine surgery products.

Medacta products have seen rapid adoption by surgeons, patients, and healthcare organizations alike since the company’s founding. To date, the company’s MyKnee Patient Matched Technology has been used in more than 15,000 procedures worldwide. In 2013, AMIStem, the first hip stem designed and launched specifically for the anterior approach to the hip, was utilized in its 50,000^th patient. Medacta documented the 100,000^th surgical procedure utilizing its AMIS Technique for Hip Arthroplasty last year as well. Medacta has entered into the spine market with precision-engineered spine implants and instruments, and is applying its proven 3D-reconstruction and rapid 3D-printing technologies to assist spine surgeons on the most complex deformity cases.

“Medacta’s vision is to help orthopedic patients live like they once did, free from pain and disability, with renewed optimism and hope,” said Dr. Alberto Siccardi, founder, president, and chief executive officer of Medacta International. “We are committed to developing products that embody our commitment to meticulous design, responsible innovation, and health economic sustainability. Medacta has grown tremendously and achieved many milestones since its founding fifteen years ago, including the expansion of our commitment to excellence in joint replacement into the care of spine pathologies, but I’m most excited about our future: the company’s experienced management team, long-term product roadmap, and education and training initiatives position it for long-term success in the years to come.”

For the first time, this year’s M.O.R.E. International Symposium will also include a distinct summit on spine care options, strategies, and treatment decisions. The International Spine Summit will run concurrently alongside the hip and knee tracks, and will include its own distinguished international faculty of more than 30 orthopedic spine and neurosurgery experts. It will also feature an honorary lecture by Max Aebi, MD, (Hirslanden Hospital Group, Switzerland) on the history and evolution of spinal instrumentation techniques. For more information on the totality of knee, hip, and spine content that will be featured over the weekend, please visit the event websites .

About Medacta® International

Medacta® International is a world leading manufacturer of orthopedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS® system and total knee replacement with MyKnee® patient matched technology. Over the last 10 years, Medacta has grown dramatically by taking a holistic approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in 26 countries. For more information about the company, please visit www.medacta.com .

Contact:

for Medacta
Hal Mackins, +1 617-379-3775
hal@torchcommunications.com